StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Jyong Biotech

Jyong Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jyong Biotech figures

See a number that looks wrong?